Uptake and bioconversion of stereoisomeric dipeptide prodrugs of ganciclovir by nanoparticulate carriers in corneal epithelial cells

References

• Adjei IM, Sharma B, Labhasetwar V. (2014). Nanoparticles: cellular uptake and cytotoxicity. Adv Exp Med Biol 811:73–91
   PubMed Web of Science ®Google Scholar
• Billaud G, Thouvenot D, Morfin F. (2009). Drug targets in herpes simplex and Epstein Barr Virus infections. Infect Disord Drug Targets 9:117–25
   PubMedGoogle Scholar
• Biron KK. (2006). Antiviral drugs for cytomegalovirus diseases. Antiviral Res 71:154–63
   PubMed Web of Science ®Google Scholar
• Decuzzi P, Ferrari M. (2007). The role of specific and non-specific interaction in receptor-mediated endocytosis of nanoparticles. Biomaterials 28:2915–22
   PubMed Web of Science ®Google Scholar
• Duan R, De Vries RD, Van Dun JM, et al. (2009). Acyclovir susceptibility and genetic characteristics of sequential herpes simplex virus type 1 corneal isolates from patients with recurrent herpetic keratitis. J Infect Dis 200:1402–14
   PubMed Web of Science ®Google Scholar
• Friedrichsen GM, Jakobsen P, Taub M, et al. (2001). Application of enzymatically stable dipeptides for enhancement of intestinal permeability: synthesis and in vitro evaluation of dipeptide-coupled compounds. Bioorg Med Chem 9:2625–32
   PubMed Web of Science ®Google Scholar
• Gunda S, Hariharan S, Mitra AK. (2006). Corneal absorption and anterior chamber pharmacokinetics of dipeptide monoester prodrugs of ganciclovir (GCV): in vivo comparative evaluation of these prodrugs with Val-GCV and GCV in rabbits. J Ocul Pharmacol Ther 22:465–76
   PubMed Web of Science ®Google Scholar
• Jwala J, Boddu SH, Shah S, et al. (2011). Ocular sustained release nanoparticles containing stereoisomeric dipeptide prodrugs of acyclovir. J Ocul Pharmacol Ther 27:163–172
   PubMed Web of Science ®Google Scholar
• Kansara V, Hao Y, Mitra AK. (2007). Dipeptide monoester ganciclovir prodrugs for transscleral drug delivery: targeting the oligopeptide transporter on rabbit retina. J Ocul Pharmacol Ther 23:321–34
   PubMed Web of Science ®Google Scholar
• Kennedy DP, Clement C, Arceneaux RL, et al. (2011). Ocular herpes simplex virus type 1: is the cornea a reservoir for viral latency or a fast pit stop? Cornea 30:251–9
   PubMed Web of Science ®Google Scholar
• Khin YW, Feng SS. (2005). Effect of particle size and surface coating on cellular uptake of polymeric nanoparticles for oral delivery of anticancer drugs. Biomaterials 26:2713–22
   PubMed Web of Science ®Google Scholar
• Macha S, Duvvuri S, Mitra AK. (2004). Ocular disposition of novel lipophilic diester prodrugs of ganciclovir following intravitreal administration using microdialysis. Curr Eye Res 28:77–84
   PubMed Web of Science ®Google Scholar
• Macha S, Mitra AK. (2002). Ocular disposition of ganciclovir and its monoester prodrugs following intravitreal administration using microdialysis. Drug Metab Dispos 30:670–5
   PubMed Web of Science ®Google Scholar
• Majumdar S, Nashed YE, Patel K, et al. (2005). Dipeptide monoester ganciclovir prodrugs for treating HSV-1-induced corneal epithelial and stromal keratitis: in vitro and in vivo evaluations. J Ocul Pharmacol Ther 21:463–74
   PubMed Web of Science ®Google Scholar
• Patel K, Trivedi S, Luo S, et al. (2005). Synthesis, physicochemical properties and antiviral activities of ester prodrugs of ganciclovir. Int J Pharm 305:75–89
   PubMed Web of Science ®Google Scholar
• Perng GC, Jones C. (2010). Towards an understanding of the herpes simplex virus type 1 latency-reactivation cycle. Interdiscip Perspect Infect Dis 2010:262415
   PubMedGoogle Scholar
• Refai H, Tag R. (2011). Development and characterization of sponge-like acyclovir ocular minitablets. Drug Deliv 18:38–45
   PubMed Web of Science ®Google Scholar
• Remeijer L, Maertzdorf J, Buitenwerf J, et al. (2002). Corneal herpes simplex virus type 1 superinfection in patients with recrudescent herpetic keratitis. Invest Ophthalmol Vis Sci 43:358–63
   PubMed Web of Science ®Google Scholar
• Shiota H, Naito T, Mimura Y. (1987). Anti-herpes simplex virus (HSV) effect of 9-(1,3-dihydroxy-2-propoxymethyl)guanine (DHPG) in rabbit cornea. Curr Eye Res 6:241–5
   PubMed Web of Science ®Google Scholar
• Talluri RS, Gaudana R, Hariharan S, et al. (2009). Pharmacokinetics of stereoisomeric dipeptide prodrugs of acyclovir following intravenous and oral administrations in rats: a study involving in vivo corneal uptake of acyclovir following oral dosing. Ophthalmol Eye Dis 1:21–31
   PubMedGoogle Scholar
• Talluri RS, Samanta SK, Gaudana R, et al. (2008). Synthesis, metabolism and cellular permeability of enzymatically stable dipeptide prodrugs of acyclovir. Int J Pharm 361:118–24
   PubMed Web of Science ®Google Scholar
• Tamura K, Bhatnagar PK, Takata JS, et al. (1996). Metabolism, uptake, and transepithelial transport of the diastereomers of Val-Val in the human intestinal cell line, Caco-2. Pharm Res 13:1213–18
   PubMed Web of Science ®Google Scholar
• Taylor JL, Punda-Polic V, O'Brien WJ. (1991). Combined anti-herpes virus activity of nucleoside analogs and interferon. Curr Eye Res 10:205–11
   PubMed Web of Science ®Google Scholar
• Tirucherai GS, Dias C, Mitra AK. (2002). Corneal permeation of ganciclovir: mechanism of ganciclovir permeation enhancement by acyl ester prodrug design. J Ocul Pharmacol Ther 18:535–48
   PubMed Web of Science ®Google Scholar
• Tirucherai GS, Mitra AK. (2003). Effect of hydroxypropyl beta cyclodextrin complexation on aqueous solubility, stability, and corneal permeation of acyl ester prodrugs of ganciclovir. AAPS PharmSciTech 4:E45
   PubMedGoogle Scholar
• Tomicic MT, Bey E, Wutzler P, et al. (2002). Comparative analysis of DNA breakage, chromosomal aberrations and apoptosis induced by the anti-herpes purine nucleoside analogues aciclovir, ganciclovir and penciclovir. Mutat Res 505:1–11
   PubMed Web of Science ®Google Scholar
• Xu F, Sternberg MR, Kottiri BJ, et al. (2006). Trends in herpes simplex virus type 1 and type 2 seroprevalence in the United States. JAMA 296:964–73
   PubMed Web of Science ®Google Scholar
• Yameen B, Choi WI, Vilos C, et al. (2014). Insight into nanoparticle cellular uptake and intracellular targeting. J Control Release 190:485–99
   PubMed Web of Science ®Google Scholar
• Yang X, Shah SJ, Wang Z, et al. (2015). Nanoparticle-based topical ophthalmic formulation for sustained release of stereoisomeric dipeptide prodrugs of ganciclovir. Drug Deliv 7:1–11
   Google Scholar